Interleukin-1β induces matrix metalloproteinase-1 expression in cultured human gingival fibroblasts: Role of cyclooxygenase-2 and prostaglandin E2

Oral Diseases

Volumn 10, Issue 2, 2004, Pages 87-93

  Sakaki, Hirotaka ^a   Matsumiya, T ^a   Kusumi, A ^a   Imaizumi, T ^a   Satoh, H ^a   Yoshida, H ^a   Satoh, K ^a   Kimura, H ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

COX 2; Human gingival fibroblasts; IL 1 ; MMP 1; PGE2; Quantitative PCR

Indexed keywords

CYCLOHEXIMIDE; CYCLOOXYGENASE 2; DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PROSTAGLANDIN E2; ENZYME INHIBITOR; INTERLEUKIN 1; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; INFLAMMATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; TIME; BIOSYNTHESIS; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CYCLOHEXIMIDE; CYCLOOXYGENASE 2; DEXAMETHASONE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GINGIVA; HUMANS; INDOMETHACIN; INTERLEUKIN-1; ISOENZYMES; MATRIX METALLOPROTEINASE 1; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 1542782902     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1354-523X.2003.00982.x     Document Type: Article

References (46)

1. Aiba T, Akeno N, Kawane T et al (1996). Matrix metalloproteinases-1 and -8 and TIMP-1 mRNA levels in normal and diseased human gingivae. Eur J Oral Sci 104: 562-569.
2. Birkedal-Hansen H (1993). Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 64: 474-484.
3. Birkedal-Hansen H (1995). Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 718-735.
4. Birkedal-Hansen H, Moore WG, Bodden MK et al (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250.
5. Bronson RE, Treat JA, Bertolami CN (1989). Fibroblastic subpopulations in uninjured and wounded rabbit oral mucosa. J Dent Res 68: 51-58.
6. Cavanaugh PF Jr, Meredith MP, Buchanan W et al (1998). Coordinate production of PGE2 and IL-1 beta in the gingival crevicular fluid of adults with periodontitis: its relationship to alveolar bone loss and disruption by twice daily treatment with ketorolac tromethamine oral rinse. J Periodontal Res 33: 75-82.
7. DeWitt DL (1991). Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim Biophys Acta 1083: 121-134.
8. Domeij H, Yucel-Lindberg T, Modeer T (2002). Signal pathways involved in the production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J Oral Sci 110: 302-306.
9. Dongari-Bagtzoglou AI, Ebersole JL (1996). Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 31: 90-98.
10. Duff G (1985). Immune diseases. Many roles for interleukin-1. Nature 313: 352-353.
11. Dzink JL, Tanner AC, Haffajee AD et al (1985). Gram negative species associated with active destructive periodontal lesions. J Clin Periodontol 12: 648-659.
12. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S et al (2003). Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 74: 188-195.
13. Fullmer HM, Gibson W (1966). Collagenolytic activity in gingivae of man. Nature 209: 728-729.
14. Goodson JM, Tanner AC, Haffajee AD et al (1982). Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontl 9: 472-481.
15. Gowen M, Wood DD, Ihrie EJ et al (1983). An interleukin 1 like factor stimulates bone resorption in vitro. Nature 306: 378-380.
16. Grandchamp B, De Verneuil H, Beaumont C et al (1987). Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. Eur J Biochem 162: 105-110.
17. Heasman PA, Offenbacher S, Collins JG et al (1993). Flurbiprofen in the prevention and treatment of experimental gingivitis. J Clin Periodontol 20: 732-738.
18. Heath JK, Atkinson SJ, Hembry RM et al (1987). Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun 55: 2148-2154.
19. Kang HS, Kim YH, Lee CS et al (1996). Suppression of interleukin-1 and tumor necrosis factor-alpha production by acanthoic acid, (-)-pimara-9(11), 15-dien-19-oic acid, and it antifibrotic effects in vivo. Cell Immunol 170: 212-221.
20. Koshy PJ, Lundy CJ, Rowan AD et al (2002). The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum 46: 961-967.
21. Krane SM (1994). Clinical importance of metalloproteinases and their inhibitors. Ann NY Acad Sci 732: 1-10.
22. Krane SM (1995). Is collagenase (matrix metalloproteinase-1) necessary for bone and other connective tissue remodeling? Clin Orthop 313: 47-53.
23. Kubota T, Nomura T, Takahashi T et al (1996). Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol 41: 253-262.
24. Kutchera W, Jones DA, Matsunami N et al (1996). Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci USA 93: 4816-4820.
25. Lin SK, Kok SH, Kuo MY et al (2002). Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats. Eur J Oral Sci 110: 246-253.
26. Long P, Liu F, Piesco NP et al (2002). Signaling by mechanical strain involves transcriptional regulation of proinflammatory genes in human periodontal ligament cells in vitro. Bone 30: 547-552.
27. Loning T, Albers HK, Lisboa BP et al (1980). Prostaglandin E and the local immune response in chronic periodontal disease. Immunohistochemical and radioimmunological observations. J Periodontal Res 15: 525-535.
28. McCulloch CA, Bordin S (1991). Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodont Res 26: 144-154.
29. MacNaul KL, Chartrain N, Lark M et al (1990). Discoordinate expression of stromelysin, collagenase and tissue inhibitor of metalloproteinases-1 in rheumatoid human synovial fibroblasts. J Biol Chem 265: 17238-17245.
30. Mariotti A (1999). Dental plaque-induced gingival diseases. Ann Periodontol 4: 7-19.
31. Matrisian LM, Wright J, Newell K et al (1994). Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symp 24: 152-161.
32. Offenbacher S, Odle BM, Van Dyke TE (1986). The use of crevicular fluid prostaglandin E2 levels as a predictor of periodontal attachment loss. J Periodontal Res 21: 101-112.
33. Offenbacher S, Heasman PA, Collins JG (1993). Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 64: 432-444.
34. Ottino P, Bazan HE (2001). Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites. Curr Eye Res 23: 77-85.
35. Page RC (1995). Critical issues in periodontal research. J Dent Res 74: 1118-1128.
36. Peled ZM, Phelps ED, Updike DL et al (2002). Matrix metalloproteinases and the ontogeny of scarless repair: the other side of the wound healing balance. Plast Reconstr Surg 110: 801-811.
37. Ries C, Petrides PE (1995). Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 376: 345-355.
38. Salvi GE, Beck JD, Offenbacher S (1998). PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression. Ann Periodontol 3: 40-50.
39. Sismey-Durrant HJ, Hopps RM (1991). Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1-beta release from rat periosteal and human gingival fibroblasts in vitro. Oral Microbiol Immunol 6: 378-380.
40. Tewari DS, Qian Y, Tewari M et al (1994). Mechanistic features associated with induction of metalloproteinases in human gingival fibroblasts by interleukin-1. Arch Oral Biol 39: 657-664.
41. Theilig C, Bernd A, Leyhausen G et al (2001). Effects of mechanical force on primary human fibroblasts derived from the gingiva and the periodontal ligament. J Dent Res 80: 1777-1780.
42. Tuter G, Kurtis B, Serdar M (2002). Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1. J Periodontol 73: 487-493.
43. Wan Y, Belt A, Wang Z et al (2001). Transmodulation of epidermal growth factor receptor mediates IL-1 beta-induced MMP-1 expression in cultured human keratinocytes. Int J Mol Med 7: 329-334.
44. Westermarck J, Kahari VM (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792.
45. Williams RC, Jeffcoat MK, Howell TH et al (1989) Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 60: 485-490.
46. Woessner JF Jr. (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154.